United States· US:0832-6083_8360dfb0-5f3a-4b86-8b46-fc89c12aad6b

Olanzapine

A olanzapine product containing olanzapine, registered in United States by Upsher-Smith Laboratories, LLC. The same ATC class is registered in 18 of our 19 countries.

ATC N05AH03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOlanzapineATCN05AH03REGISTER NO.US:0832-6083_8360dfb0…PACKS LISTED4CHECKEDAugust 30, 2026

Where it is registered

Olanzapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N05AH03 (olanzapine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Olanzapine · ATC N05AH03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olanzapine costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in United States to $3.34 in Switzerland — a ×19 gap.

  • United States: $0.17 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Olanzapine · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.34
  • IT Italy$1.59
  • FR France$0.63
  • US United States$0.17 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OLANZAPINE
Manufacturer
Upsher-Smith Laboratories, LLC
Country
United States (US)
ATC code
N05AH03
ATC class
Olanzapine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 30, 2026

Packs & prices · 4

  • ndc11
    0832608303
    30 TABLET in 1 BOTTLE (0832-6083-03)
  • ndc11
    0832608350
    500 TABLET in 1 BOTTLE (0832-6083-50)
  • ndc11
    0832-6083-03
  • ndc11
    0832-6083-50

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

481 interactions on record for olanzapine.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olanzapine · interactions on record

481 records

  • 14 severe
  • 292 moderate
  • 3 minor
  • 137 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe

35 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/21816656-a476-4d43-a491-6193a0e80491
GET /v1/drugs/21816656-a476-4d43-a491-6193a0e80491?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20",
  "substance": "OLANZAPINE",
  "productndc": "0832-6083",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204319",
  "marketing_category": "ANDA"
}

See everything about olanzapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.